Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis Versus Placebo in High Risk Surgical Subjects - A Multicentre, Randomized, Double-blind Study

NCT01122368 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01122368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01122368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis Versus Placebo in High Risk Surgical Subjects - A Multicentre, Randomized, Double-blind Study
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
July 13, 2010
Completion date
December 15, 2011
Enrollment
252 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

mycoses